The prominent researcher has been put on administrative leave pending an investigation into unspecified allegations.
William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.
William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.
Mice treated with an immunostimulant had better outcomes when researchers blocked the expression of TNFR2, a compound that helps tumors evade immune attack.
Motivated by his father’s cancer diagnosis, the Francis Crick Institute cancer geneticist has been revealing the ways tumors evolve and why they are so difficult to treat.
In the presence of cytosolic DNA, cancer cells activate antiviral pathways that disguise them as immune cells.
Meet some of the people featured in the April 2018 issue of The Scientist.
A new device uses anchored nanowires to capture extracellular vesicles from pee for microRNA analysis.
Mutations in the TP53 gene appear to influence the prognosis and likelihood of future cancers in pediatric leukemia patients.
The research enterprise surrounding cancer spreads and changes as it explores multiple facets of the complex disease.
Mice with cancer whose KRAS proteins couldn’t link together had much better survival outcomes than those whose oncogenic mutant paired with wild-type KRAS.